We aim to focus on different metallomics profiles in these cells, trying to find a new role of the surface membrane glycans and transmembrane-intracellular signals addressing the resistance phenomenon frequently observed in malignant melanoma harboring multiple BRAF mutation. Here, BRAF is linked to melanoma.